Investment House LLC Has $14.27 Million Position in iShares Biotechnology ETF $IBB

Investment House LLC increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 98,821 shares of the financial services provider’s stock after buying an additional 3,873 shares during the quarter. Investment House LLC owned 0.24% of iShares Biotechnology ETF worth $14,267,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of IBB. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the 2nd quarter worth approximately $25,000. Berkshire Money Management Inc. acquired a new stake in shares of iShares Biotechnology ETF in the second quarter valued at approximately $28,000. Financial Gravity Companies Inc. bought a new stake in shares of iShares Biotechnology ETF in the second quarter worth $29,000. Ashton Thomas Securities LLC bought a new stake in shares of iShares Biotechnology ETF in the third quarter worth $36,000. Finally, Harbor Asset Planning Inc. acquired a new position in iShares Biotechnology ETF during the second quarter worth $31,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.3%

iShares Biotechnology ETF stock opened at $175.33 on Friday. iShares Biotechnology ETF has a 1-year low of $107.43 and a 1-year high of $179.64. The company has a fifty day simple moving average of $170.55 and a 200 day simple moving average of $153.10.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Tuesday, December 16th were issued a $0.1831 dividend. This represents a $0.73 annualized dividend and a dividend yield of 0.4%. The ex-dividend date was Tuesday, December 16th. This is a positive change from iShares Biotechnology ETF’s previous quarterly dividend of $0.08.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.